Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ischemic Heart Disease

Free Subscription Articles published in JAMA Retrieve available abstracts of 148 articles: HTML format

Single Articles

April 2024
1. HARRIS E
   Study Examines Intermittent Fasting and Cardiovascular Mortality.
   JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5158.
   PubMed    
   
   
   
2. WU F, Jacobs DR Jr, Daniels SR, Kahonen M, et al
   Non-High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events.
   JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4819.
   PubMed     Abstract available
   
   
   March 2024
3. HARRIS E
   Plastic in Arteries Tied With Higher Risk of Cardiovascular Problems.
   JAMA. 2024 Mar 29. doi: 10.1001/jama.2024.3707.
   PubMed    
   
   
   
4. YEH RW, Shlofmitz R, Moses J, Bachinsky W, et al
   Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical Trial.
   JAMA. 2024;331:1015-1024.
   PubMed     Abstract available
   
   
   
5. KUNDU A, Moliterno DJ
   Drug-Coated Balloons for In-Stent Restenosis-Finally Leaving Nothing Behind for US Patients.
   JAMA. 2024;331:1011-1012.
   PubMed    
   
   
   
6. HARRIS E
   Meta-Analysis: Cardiovascular Risks Rose After Stopping Aspirin.
   JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2091.
   PubMed    
   
   
   
7. XU J
   Sintilimab and Cardiovascular Toxicity-Reply.
   JAMA. 2024 Mar 21. doi: 10.1001/jama.2024.0676.
   PubMed    
   
   
   
8. PENG L, Yang D, Weng C
   Sintilimab and Cardiovascular Toxicity.
   JAMA. 2024 Mar 21. doi: 10.1001/jama.2024.0673.
   PubMed    
   
   
   
9. CHEN G, Shang M, Yang Y
   Traditional Chinese Medicine Compound and Clinical Outcomes in Acute Myocardial Infarction-Reply.
   JAMA. 2024 Mar 20. doi: 10.1001/jama.2024.0617.
   PubMed    
   
   
   
10. ZAKIEV V, Gvozdeva A, Skotnikov A
    Traditional Chinese Medicine Compound and Clinical Outcomes in Acute Myocardial Infarction.
    JAMA. 2024 Mar 20. doi: 10.1001/jama.2024.0620.
    PubMed    
    
    
    
11. ASHAM H, Entezari-Maleki T
    Traditional Chinese Medicine Compound and Clinical Outcomes in Acute Myocardial Infarction.
    JAMA. 2024 Mar 20. doi: 10.1001/jama.2024.0623.
    PubMed    
    
    
    
12. HARRIS E
    Blood Test Predicted Risk of Future Heart Attacks.
    JAMA. 2024;331:908.
    PubMed    
    
    
    
13. ANDERER S
    Cannabis Use Linked to Elevated Myocardial Infarction and Stroke Risk.
    JAMA. 2024 Mar 15. doi: 10.1001/jama.2024.2075.
    PubMed    
    
    
    
14. KO D, Pascual-Leone A, Shah SJ
    Use of Lecanemab for Patients With Cardiovascular Disease: The Challenge of Uncertainty.
    JAMA. 2024 Mar 15. doi: 10.1001/jama.2024.2991.
    PubMed    
    
    
    
15. HARRIS E
    High Niacin Levels May Raise Cardiovascular Disease Risk.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1566.
    PubMed    
    
    
    January 2024
16. BELL KJL, Glasziou PP, Doust JA
    Gestational Diabetes and Cardiovascular Health.
    JAMA. 2024;331:167.
    PubMed    
    
    
    
17. VENKATESH KK, Khan SS, Powe CE
    Gestational Diabetes and Cardiovascular Health-Reply.
    JAMA. 2024;331:167-168.
    PubMed    
    
    
    December 2023
18. LARKIN H
    What to Know About PREVENT, the AHA's New Cardiovascular Disease Risk Calculator.
    JAMA. 2023 Dec 27. doi: 10.1001/jama.2023.25115.
    PubMed    
    
    
    
19. HARRIS E
    Long-Term ADHD Medications and Cardiovascular Disease Risk.
    JAMA. 2023 Dec 6. doi: 10.1001/jama.2023.24173.
    PubMed    
    
    
    November 2023
20. HARRIS E
    Semaglutide Improved Cardiovascular Health in People Without Diabetes.
    JAMA. 2023 Nov 29. doi: 10.1001/jama.2023.23508.
    PubMed    
    
    
    
21. KHAN SS, Grobman WA, Cameron NA
    Cardiovascular Health in the Postpartum Period.
    JAMA. 2023 Nov 15. doi: 10.1001/jama.2023.19192.
    PubMed    
    
    
    
22. LARKIN H
    Here's What to Know About Cardiovascular-Kidney-Metabolic Syndrome, Newly Defined by the AHA.
    JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.22276.
    PubMed    
    
    
    
23. GOLDSTEIN MR, Mascitelli L
    Bempedoic Acid for Primary Prevention of Cardiovascular Events.
    JAMA. 2023;330:1696.
    PubMed    
    
    
    
24. NISSEN SE, Nicholls SJ, Lincoff AM
    Bempedoic Acid for Primary Prevention of Cardiovascular Events-Reply.
    JAMA. 2023;330:1696-1697.
    PubMed    
    
    
    October 2023
25. CURFMAN G
    Traditional Chinese Medicine for ST-Segment Elevation Myocardial Infarction.
    JAMA. 2023;330:1546.
    PubMed    
    
    
    
26. YANG Y, Li X, Chen G, Xian Y, et al
    Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction: The CTS-AMI Randomized Clinical Trial.
    JAMA. 2023;330:1534-1545.
    PubMed     Abstract available
    
    
    
27. BACH RG
    Traditional Chinese Medicine Meets Evidence-Based Medicine in the Acutely Infarcted Heart.
    JAMA. 2023;330:1529-1530.
    PubMed    
    
    
    
28. TAJEU GS, Joynt Maddox K, Brewer LC
    Million Hearts Cardiovascular Disease Risk Reduction Model.
    JAMA. 2023;330:1430-1432.
    PubMed    
    
    
    
29. JURASCHEK SP, Hu JR, Cluett JL, Ishak AM, et al
    Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-Analysis.
    JAMA. 2023;330:1459-1471.
    PubMed     Abstract available
    
    
    
30. BLUE L, Kranker K, Markovitz AR, Powell RE, et al
    Effects of the Million Hearts Model on Myocardial Infarctions, Strokes, and Medicare Spending: A Randomized Clinical Trial.
    JAMA. 2023;330:1437-1447.
    PubMed     Abstract available
    
    
    
31. SANCHEZ-DE-LA-TORRE M, Gracia-Lavedan E, Benitez ID, Sanchez-de-la-Torre A, et al
    Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events: A Meta-Analysis.
    JAMA. 2023;330:1255-1265.
    PubMed     Abstract available
    
    
    September 2023
32. KAZI DS, Wadhera RK, Rome BN
    The Inflation Reduction Act and Access to High-Cost Cardiovascular Therapies.
    JAMA. 2023 Sep 20. doi: 10.1001/jama.2023.19129.
    PubMed    
    
    
    
33. HARRIS E
    Semaglutide Improves Heart Failure and Cardiovascular Disease.
    JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16674.
    PubMed    
    
    
    August 2023
34. HSU NC, Fu YC, Hsu CH
    Coordinated Care for Optimization of Cardiovascular Preventive Therapies in Patients With Diabetes.
    JAMA. 2023;330:771.
    PubMed    
    
    
    
35. PAGIDIPATI NJ, Granger CB, Nelson A
    Coordinated Care for Optimization of Cardiovascular Preventive Therapies in Patients With Diabetes-Reply.
    JAMA. 2023;330:771-772.
    PubMed    
    
    
    
36. YOO SGK, Chung GS, Bahendeka SK, Sibai AM, et al
    Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income Countries.
    JAMA. 2023;330:715-724.
    PubMed     Abstract available
    
    
    
37. HELGASON H, Eiriksdottir T, Ulfarsson MO, Choudhary A, et al
    Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular Events.
    JAMA. 2023;330:725-735.
    PubMed     Abstract available
    
    
    
38. HARRIS E
    How Sleep Apnea Contributes to Cardiovascular Disease.
    JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.13939.
    PubMed    
    
    
    
39. KAWADA T
    Treating Coronary Artery Disease With Treat-to-Target or High-Intensity Statin.
    JAMA. 2023;330:470-471.
    PubMed    
    
    
    
40. HONG SJ, Lee YJ, Hong MK
    Treating Coronary Artery Disease With Treat-to-Target or High-Intensity Statin-Reply.
    JAMA. 2023;330:471.
    PubMed    
    
    
    July 2023
41. GOLDENBERG E
    Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults.
    JAMA. 2023;330:379.
    PubMed    
    
    
    
42. AGGARWAL R, Wadhera RK
    Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults-Reply.
    JAMA. 2023;330:379-380.
    PubMed    
    
    
    
43. CAMERON NA, Yee LM, Dolan BM, O'Brien MJ, et al
    Trends in Cardiovascular Health Counseling Among Postpartum Individuals.
    JAMA. 2023;330:359-367.
    PubMed     Abstract available
    
    
    
44. KHURSHID S, Al-Alusi MA, Churchill TW, Guseh JS, et al
    Accelerometer-Derived "Weekend Warrior" Physical Activity and Incident Cardiovascular Disease.
    JAMA. 2023;330:247-252.
    PubMed     Abstract available
    
    
    
45. AGGARWAL R, Chiu N, Libby P, Boden WE, et al
    Low-Density Lipoprotein Cholesterol Levels in Adults With Coronary Artery Disease in the US, January 2015 to March 2020.
    JAMA. 2023;330:80-82.
    PubMed    
    
    
    
46. GELLERT GA, Jaszczak J
    Cardiovascular Disease Prevention Recommendations From an Online Chat-Based AI Model.
    JAMA. 2023;330:82-83.
    PubMed    
    
    
    
47. SARRAJU A, Rodriguez F, Laffin L
    Cardiovascular Disease Prevention Recommendations From an Online Chat-Based AI Model-Reply.
    JAMA. 2023;330:83.
    PubMed    
    
    
    June 2023
48. HARRIS E
    Testosterone Therapy Did Not Increase Major Cardiovascular Events.
    JAMA. 2023 Jun 28. doi: 10.1001/jama.2023.11959.
    PubMed    
    
    
    
49. KAZI DS
    Bempedoic Acid for High-Risk Primary Prevention of Cardiovascular Disease: Not a Statin Substitute but a Good Plan B.
    JAMA. 2023 Jun 24. doi: 10.1001/jama.2023.9854.
    PubMed    
    
    
    
50. NISSEN SE, Menon V, Nicholls SJ, Brennan D, et al
    Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients.
    JAMA. 2023 Jun 24. doi: 10.1001/jama.2023.9696.
    PubMed     Abstract available
    
    
    
51. HARRIS E
    Sex Differences in Post-Heart Attack Rehospitalizations.
    JAMA. 2023;329:1817-1818.
    PubMed    
    
    
    May 2023
52. KHAN SS, Post WS, Guo X, Tan J, et al
    Coronary Artery Calcium Score and Polygenic Risk Score for the Prediction of Coronary Heart Disease Events.
    JAMA. 2023;329:1768-1777.
    PubMed     Abstract available
    
    
    April 2023
53. ROEHM E
    Medicare Advantage vs Traditional Medicare and 30-Day Mortality in Patients With AMI.
    JAMA. 2023;329:1121.
    PubMed    
    
    
    
54. LANDON BE, Curto V, Ayanian JZ
    Medicare Advantage vs Traditional Medicare and 30-Day Mortality in Patients With AMI-Reply.
    JAMA. 2023;329:1121-1122.
    PubMed    
    
    
    
55. LANDON BE, Hatfield LA, Bakx P, Banerjee A, et al
    Differences in Treatment Patterns and Outcomes of Acute Myocardial Infarction for Low- and High-Income Patients in 6 Countries.
    JAMA. 2023;329:1088-1097.
    PubMed     Abstract available
    
    
    March 2023
56. HONG SJ, Lee YJ, Lee SJ, Hong BK, et al
    Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial.
    JAMA. 2023 Mar 6:e232487. doi: 10.1001/jama.2023.2487.
    PubMed     Abstract available
    
    
    
57. PAGIDIPATI NJ, Nelson AJ, Kaltenbach LA, Leyva M, et al
    Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial.
    JAMA. 2023 Mar 6:e232854. doi: 10.1001/jama.2023.2854.
    PubMed     Abstract available
    
    
    
58. AGGARWAL R, Yeh RW, Joynt Maddox KE, Wadhera RK, et al
    Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020.
    JAMA. 2023 Mar 5:e232307. doi: 10.1001/jama.2023.2307.
    PubMed     Abstract available
    
    
    
59. ALLEN N, Wilkins JT
    The Urgent Need to Refocus Cardiovascular Disease Prevention Efforts on Young Adults.
    JAMA. 2023 Mar 5. doi: 10.1001/jama.2023.2308.
    PubMed    
    
    
    
60. RUDER K
    Large Study Finds Women Are (Still) Much More Likely to Die or Have Complications After Coronary Artery Bypass Graft Surgery Than Men.
    JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.1806.
    PubMed    
    
    
    February 2023
61. CHU WM, Wang CY, Wei JC
    Vaccination, Acute Myocardial Infarction, and Ischemic Stroke After COVID-19 Infection.
    JAMA. 2023;329:426.
    PubMed    
    
    
    
62. HUH K, Kim YE, Jung J
    Vaccination, Acute Myocardial Infarction, and Ischemic Stroke After COVID-19 Infection-Reply.
    JAMA. 2023;329:426-427.
    PubMed    
    
    
    
63. SEDERHOLM LAWESSON S, Swahn E, Pihlsgard M, Andersson T, et al
    Association Between History of Adverse Pregnancy Outcomes and Coronary Artery Disease Assessed by Coronary Computed Tomography Angiography.
    JAMA. 2023;329:393-404.
    PubMed     Abstract available
    
    
    
64. SARRAJU A, Bruemmer D, Van Iterson E, Cho L, et al
    Appropriateness of Cardiovascular Disease Prevention Recommendations Obtained From a Popular Online Chat-Based Artificial Intelligence Model.
    JAMA. 2023 Feb 3. doi: 10.1001/jama.2023.1044.
    PubMed    
    
    
    January 2023
65. HARRIS E
    Changes in p53 Gene May Influence Cardiovascular Disease Risk.
    JAMA. 2023 Jan 25. doi: 10.1001/jama.2023.0387.
    PubMed    
    
    
    
66. FONSECA AC
    Gout Flare and Cardiovascular Events.
    JAMA. 2023;329:96.
    PubMed    
    
    
    
67. CIPOLLETTA E, Tata LJ, Abhishek A
    Gout Flare and Cardiovascular Events-Reply.
    JAMA. 2023;329:96-97.
    PubMed    
    
    
    December 2022
68. DORRILL RA, Ashcraft A, Taitsman J
    Trends in Adverse Event Rates Among Hospitalized Patients From 2010 to 2019.
    JAMA. 2022;328:2271-2272.
    PubMed    
    
    
    
69. ELDRIDGE N, Metersky M, Grace E
    Trends in Adverse Event Rates Among Hospitalized Patients From 2010 to 2019-Reply.
    JAMA. 2022;328:2272-2273.
    PubMed    
    
    
    
70. ZENG BY, Tseng PT, Liang CS
    Dual Antiplatelet Therapy With Ticagrelor and Vein Graft Failure After Coronary Artery Bypass Graft Surgery.
    JAMA. 2022;328:2273.
    PubMed    
    
    
    
71. SANDNER S, Redfors B, Gaudino M
    Dual Antiplatelet Therapy With Ticagrelor and Vein Graft Failure After Coronary Artery Bypass Graft Surgery-Reply.
    JAMA. 2022;328:2273-2274.
    PubMed    
    
    
    
72. SURAN M
    Cardiovascular Corner-Researchers Probe Factors That May Contribute to Cardiovascular Health Disparities.
    JAMA. 2022 Dec 7. doi: 10.1001/jama.2022.22283.
    PubMed    
    
    
    
73. LANDON BE, Anderson TS, Curto VE, Cram P, et al
    Association of Medicare Advantage vs Traditional Medicare With 30-Day Mortality Among Patients With Acute Myocardial Infarction.
    JAMA. 2022;328:2126-2135.
    PubMed     Abstract available
    
    
    November 2022
74. PAL N, Kertai MD, Butterworth J
    Fluid Bolus Administration and Cardiovascular Collapse in Critically Ill Patients Undergoing Tracheal Intubation.
    JAMA. 2022;328:2070-2071.
    PubMed    
    
    
    
75. TEJPAL A, Parotto M, Sklar MC
    Fluid Bolus Administration and Cardiovascular Collapse in Critically Ill Patients Undergoing Tracheal Intubation.
    JAMA. 2022;328:2069-2070.
    PubMed    
    
    
    
76. VAN DER VEN WH, Vlaar APJ, Veelo DP
    Fluid Bolus Administration and Cardiovascular Collapse in Critically Ill Patients Undergoing Tracheal Intubation.
    JAMA. 2022;328:2070.
    PubMed    
    
    
    
77. RUSSELL DW, Casey JD, Semler MW
    Fluid Bolus Administration and Cardiovascular Collapse in Critically Ill Patients Undergoing Tracheal Intubation-Reply.
    JAMA. 2022;328:2071-2072.
    PubMed    
    
    
    
78. OSERAN AS, Yeh RW
    Time to Treatment in ST-Segment Elevation Myocardial Infarction: Identifying Dangerous Delays or Diminishing Returns?
    JAMA. 2022 Nov 6. pii: 2798441. doi: 10.1001/jama.2022.19441.
    PubMed    
    
    
    
79. JOLLIS JG, Granger CB, Zegre-Hemsey JK, Henry TD, et al
    Treatment Time and In-Hospital Mortality Among Patients With ST-Segment Elevation Myocardial Infarction, 2018-2021.
    JAMA. 2022 Nov 6. pii: 2798440. doi: 10.1001/jama.2022.20149.
    PubMed     Abstract available
    
    
    October 2022
80. SPENCE JD, Hankey GJ
    USPSTF Recommendations on Vitamin and Mineral Supplements for Primary Prevention of Cardiovascular Disease and Cancer.
    JAMA. 2022;328:1562-1563.
    PubMed    
    
    
    
81. MANGIONE C, Barry M, Wong J
    USPSTF Recommendations on Vitamin and Mineral Supplements for Primary Prevention of Cardiovascular Disease and Cancer-Reply.
    JAMA. 2022;328:1563-1564.
    PubMed    
    
    
    
82. KE C, Lipscombe LL, Weisman A, Zhou L, et al
    Trends in the Association Between Diabetes and Cardiovascular Events, 1994-2019.
    JAMA. 2022 Oct 14. pii: 2797494. doi: 10.1001/jama.2022.14914.
    PubMed    
    
    
    September 2022
83. HUDSON JA, Majonga ED, Ferrand RA, Perel P, et al
    Association of HIV Infection With Cardiovascular Pathology Based on Advanced Cardiovascular Imaging: A Systematic Review.
    JAMA. 2022;328:951-962.
    PubMed     Abstract available
    
    
    
84. FEINSTEIN MJ
    HIV, Subclinical Cardiovascular Disease, and Clinical Progression: Insights From Immunologic Heterogeneity.
    JAMA. 2022;328:931-932.
    PubMed    
    
    
    
85. CALDERON AT, Sanz-Sanchez J, Garcia-Garcia HM
    Alirocumab Added to High-Intensity Statin Therapy and Coronary Atherosclerosis in Patients With Acute Myocardial Infarction.
    JAMA. 2022;328:891.
    PubMed    
    
    
    
86. BENSON VM
    Alirocumab Added to High-Intensity Statin Therapy and Coronary Atherosclerosis in Patients With Acute Myocardial Infarction.
    JAMA. 2022;328:890-891.
    PubMed    
    
    
    
87. RABER L, Koskinas KC
    Alirocumab Added to High-Intensity Statin Therapy and Coronary Atherosclerosis in Patients With Acute Myocardial Infarction-Reply.
    JAMA. 2022;328:891-892.
    PubMed    
    
    
    
88. SLOMSKI A
    Benefit of Dapagliflozin When Used With Cardiovascular Medications in Patients With Type 2 Diabetes.
    JAMA. 2022;328:817.
    PubMed    
    
    
    
89. JAMES MT, Har BJ, Tyrrell BD, Faris PD, et al
    Effect of Clinical Decision Support With Audit and Feedback on Prevention of Acute Kidney Injury in Patients Undergoing Coronary Angiography: A Randomized Clinical Trial.
    JAMA. 2022;328:839-849.
    PubMed     Abstract available
    
    
    August 2022
90. CHOU R, Cantor A, Dana T, Wagner J, et al
    Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2022;328:754-771.
    PubMed     Abstract available
    
    
    
91. JIN J
    Statins for the Prevention of Cardiovascular Disease.
    JAMA. 2022;328:786.
    PubMed    
    
    
    
92. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022;328:746-753.
    PubMed     Abstract available
    
    
    
93. LO RE V 3RD, Dutcher SK, Connolly JG, Perez-Vilar S, et al
    Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients.
    JAMA. 2022;328:637-651.
    PubMed     Abstract available
    
    
    
94. SARKAR U, Bibbins-Domingo K
    Achieving Diagnostic Equity in Cardiovascular Disease.
    JAMA. 2022 Aug 15. pii: 2795499. doi: 10.1001/jama.2022.14424.
    PubMed    
    
    
    
95. LI L, Scott CA, Rothwell PM
    Association of Younger vs Older Ages With Changes in Incidence of Stroke and Other Vascular Events, 2002-2018.
    JAMA. 2022;328:563-574.
    PubMed     Abstract available
    
    
    
96. RAO SV, Ohman EM
    Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery.
    JAMA. 2022;328:532-533.
    PubMed    
    
    
    
97. WUNNAVA S, Miller TA, Narang C, Nathan M, et al
    US Food and Drug Administration Approval of High-risk Cardiovascular Devices for Use in Children and Adolescents, 1977-2021.
    JAMA. 2022;328:580-582.
    PubMed    
    
    
    
98. SANDNER S, Redfors B, Angiolillo DJ, Audisio K, et al
    Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis.
    JAMA. 2022;328:554-562.
    PubMed     Abstract available
    
    
    
99. ANDERSON JL, Knowlton KU
    Cardiovascular Events and Gout Flares.
    JAMA. 2022;328:425-426.
    PubMed    
    
    
    
100. CIPOLLETTA E, Tata LJ, Nakafero G, Avery AJ, et al
     Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout.
     JAMA. 2022;328:440-450.
     PubMed     Abstract available
     
     
     July 2022
101. PATNODE CD, Redmond N, Iacocca MO, Henninger M, et al
     Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Evidence Report and Systematic Review for the US Preventive
     JAMA. 2022;328:375-388.
     PubMed     Abstract available
     
     
     
102. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
     Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: US Preventive Services Task Force Recommendation Statement.
     JAMA. 2022;328:367-374.
     PubMed     Abstract available
     
     
     
103. SHUFELT CL, Mora S, Manson JE
     Aspirin for the Primary Prevention of Atherosclerotic Cardiovascular Disease in Women.
     JAMA. 2022 Jul 25. pii: 2794800. doi: 10.1001/jama.2022.11951.
     PubMed    
     
     
     
104. KIM YE, Huh K, Park YJ, Peck KR, et al
     Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection.
     JAMA. 2022 Jul 22. pii: 2794753. doi: 10.1001/jama.2022.12992.
     PubMed    
     
     
     
105. LINDLEY KJ, Teal SB
     Contraception in Women With Cardiovascular Disease.
     JAMA. 2022 Jul 22. pii: 2794754. doi: 10.1001/jama.2022.11541.
     PubMed    
     
     
     
106. ABBASI J
     MASALA Study Probes Why People With South Asian Ancestry Have Increased Cardiovascular Disease Risks.
     JAMA. 2022 Jul 13. pii: 2794433. doi: 10.1001/jama.2022.11417.
     PubMed    
     
     
     
107. ELDRIDGE N, Wang Y, Metersky M, Eckenrode S, et al
     Trends in Adverse Event Rates in Hospitalized Patients, 2010-2019.
     JAMA. 2022;328:173-183.
     PubMed     Abstract available
     
     
     
108. SLOMSKI A
     High HDL Cholesterol Linked With Death in Coronary Artery Disease.
     JAMA. 2022;328:10.
     PubMed    
     
     
     June 2022
109. JIN J
     Vitamins and Minerals to Prevent Cardiovascular Disease and Cancer.
     JAMA. 2022;327:2364.
     PubMed    
     
     
     
110. O'CONNOR EA, Evans CV, Ivlev I, Rushkin MC, et al
     Vitamin and Mineral Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
     JAMA. 2022;327:2334-2347.
     PubMed     Abstract available
     
     
     
111. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
     Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement.
     JAMA. 2022;327:2326-2333.
     PubMed     Abstract available
     
     
     
112. RUSSELL DW, Casey JD, Gibbs KW, Ghamande S, et al
     Effect of Fluid Bolus Administration on Cardiovascular Collapse Among Critically Ill Patients Undergoing Tracheal Intubation: A Randomized Clinical Trial.
     JAMA. 2022 Jun 16. pii: 2793545. doi: 10.1001/jama.2022.9792.
     PubMed     Abstract available
     
     
     May 2022
113. UEMURA T
     Moderate Hypothermia vs Normothermia and 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial ECMO.
     JAMA. 2022;327:1928.
     PubMed    
     
     
     
114. PAPPALARDO F, Montisci A
     Moderate Hypothermia vs Normothermia and 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial ECMO.
     JAMA. 2022;327:1927-1928.
     PubMed    
     
     
     
115. LEVY B, Combes A, Girerd N
     Moderate Hypothermia vs Normothermia and 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial ECMO-Reply.
     JAMA. 2022;327:1928-1929.
     PubMed    
     
     
     April 2022
116. DAVIDSON KW, Barry MJ, Mangione CM, Cabana M, et al
     Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.
     JAMA. 2022;327:1577-1584.
     PubMed     Abstract available
     
     
     
117. BRETT AS
     Should Patients Take Aspirin for Primary Cardiovascular Prevention?: Updated Recommendations From the US Preventive Services Task Force.
     JAMA. 2022;327:1552-1554.
     PubMed    
     
     
     
118. JIN J
     Use of Aspirin to Prevent Cardiovascular Disease.
     JAMA. 2022;327:1624.
     PubMed    
     
     
     
119. GUIRGUIS-BLAKE JM, Evans CV, Perdue LA, Bean SI, et al
     Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
     JAMA. 2022;327:1585-1597.
     PubMed     Abstract available
     
     
     
120. DEHMER SP, O'Keefe LR, Evans CV, Guirguis-Blake JM, et al
     Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the US Preventive Services Task Force.
     JAMA. 2022;327:1598-1607.
     PubMed     Abstract available
     
     
     
121. ABBASI J
     Highlights From the American College of Cardiology's Scientific Sessions-New Heart Failure Management Guidelines, Alirocumab After a Myocardial Infarction, and Treating Mild Chronic Hypertension in Pregnancy.
     JAMA. 2022 Apr 20. pii: 2791572. doi: 10.1001/jama.2022.5487.
     PubMed    
     
     
     
122. RABER L, Ueki Y, Otsuka T, Losdat S, et al
     Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.
     JAMA. 2022 Apr 3. pii: 2790913. doi: 10.1001/jama.2022.5218.
     PubMed     Abstract available
     
     
     March 2022
123. BRUXVOORT K, Slezak J, Qian L, Sy LS, et al
     Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction.
     JAMA. 2022 Mar 25. pii: 2790492. doi: 10.1001/jama.2022.2540.
     PubMed     Abstract available
     
     
     
124. LIN YH
     Mental Stress-Induced Myocardial Ischemia and Cardiovascular Events in Patients With Coronary Heart Disease.
     JAMA. 2022;327:1091.
     PubMed    
     
     
     
125. VACCARINO V, Bremner JD, Quyyumi AA
     Mental Stress-Induced Myocardial Ischemia and Cardiovascular Events in Patients With Coronary Heart Disease-Reply.
     JAMA. 2022;327:1091-1092.
     PubMed    
     
     
     
126. ABBASI J
     The COVID Heart-One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks.
     JAMA. 2022 Mar 2. pii: 2789793. doi: 10.1001/jama.2022.2411.
     PubMed    
     
     
     
127. DALZELL JR
     Review of Cardiogenic Shock After Acute Myocardial Infarction.
     JAMA. 2022;327:878.
     PubMed    
     
     
     
128. SAMSKY MD, Rao SV
     Review of Cardiogenic Shock After Acute Myocardial Infarction-Reply.
     JAMA. 2022;327:879.
     PubMed    
     
     
     February 2022
129. BHATT DL, Lopes RD, Harrington RA
     Diagnosis and Treatment of Acute Coronary Syndromes: A Review.
     JAMA. 2022;327:662-675.
     PubMed     Abstract available
     
     
     
130. LEVY B, Girerd N, Amour J, Besnier E, et al
     Effect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Clinical Trial.
     JAMA. 2022;327:442-453.
     PubMed     Abstract available
     
     
     January 2022
131. ABBASI J
     Highlights From the American Heart Association's Scientific Sessions-ApoB as a Risk Marker, an Oral PCSK9 Inhibitor, and Aspirin and Dementia.
     JAMA. 2022;327:310-312.
     PubMed    
     
     
     December 2021
132. SLOMSKI A
     Tirzepatide Tested for Type 2 Diabetes With High Cardiovascular Risk.
     JAMA. 2021;326:2464.
     PubMed    
     
     
     
133. GREENE SJ, Butler J, Fonarow GC
     Contextualizing Risk Among Patients With Heart Failure.
     JAMA. 2021;326:2261-2262.
     PubMed    
     
     
     
134. RAY KK, Wright RS
     Clinical Update on Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk.
     JAMA. 2021;326:2205.
     PubMed    
     
     
     
135. WILKINS JT, Lloyd-Jones DM
     Clinical Update on Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk-Reply.
     JAMA. 2021;326:2205-2206.
     PubMed    
     
     
     November 2021
136. NACHTIGALL M, Nachtigall RH
     The Role of Lipoprotein(a) in Cardiovascular Diseases.
     JAMA. 2021;326:2078.
     PubMed    
     
     
     
137. NATARAJAN P, Miksenas H, Januzzi JL Jr
     The Role of Lipoprotein(a) in Cardiovascular Diseases-Reply.
     JAMA. 2021;326:2078-2079.
     PubMed    
     
     
     
138. SLOMSKI A
     Intensive Blood Pressure Control Lowers Cardiovascular Risk.
     JAMA. 2021;326:2001.
     PubMed    
     
     
     
139. JABAGI MJ, Botton J, Bertrand M, Weill A, et al
     Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
     JAMA. 2021 Nov 22. pii: 2786667. doi: 10.1001/jama.2021.21699.
     PubMed    
     
     
     
140. AMINIAN A, Al-Kurd A, Wilson R, Bena J, et al
     Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
     JAMA. 2021 Nov 11. pii: 2786270. doi: 10.1001/jama.2021.19569.
     PubMed     Abstract available
     
     
     
141. VACCARINO V, Almuwaqqat Z, Kim JH, Hammadah M, et al
     Association of Mental Stress-Induced Myocardial Ischemia With Cardiovascular Events in Patients With Coronary Heart Disease.
     JAMA. 2021;326:1818-1828.
     PubMed     Abstract available
     
     
     
142. SAMSKY MD, Morrow DA, Proudfoot AG, Hochman JS, et al
     Cardiogenic Shock After Acute Myocardial Infarction: A Review.
     JAMA. 2021;326:1840-1850.
     PubMed     Abstract available
     
     
     
143. BRAVO PE, Cappola TP
     Mental Stress-Induced Myocardial Ischemia: When the Mind Controls the Fate of the Heart.
     JAMA. 2021;326:1803-1804.
     PubMed    
     
     
     October 2021
144. SAAD M, Kennedy KF, Imran H, Louis DW, et al
     Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction.
     JAMA. 2021 Oct 29. pii: 2785893. doi: 10.1001/jama.2021.18890.
     PubMed     Abstract available
     
     
     
145. FANAROFF AC, Garcia S, Giri J
     Myocardial Infarction During the COVID-19 Pandemic.
     JAMA. 2021 Oct 29. pii: 2785894. doi: 10.1001/jama.2021.19608.
     PubMed    
     
     
     
146. HE J, Zhu Z, Bundy JD, Dorans KS, et al
     Trends in Cardiovascular Risk Factors in US Adults by Race and Ethnicity and Socioeconomic Status, 1999-2018.
     JAMA. 2021;326:1286-1298.
     PubMed     Abstract available
     
     
     September 2021
147. ZUIN M, Rigatelli G, Zuliani G
     Association of Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention With Memory Decline in Older Adults.
     JAMA. 2021;326:1212-1213.
     PubMed    
     
     
     
148. WHITLOCK EL, Glymour MM
     Association of Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention With Memory Decline in Older Adults-Reply.
     JAMA. 2021;326:1213.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.